Nanomi
Manufacturing · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Zutphenstraat 51, Oldenzaal, Overijssel,...Phone Number
+31 880040800Website
www.nanomi.comRevenue
$11.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nanomi
Nanomi is a Dutch drug delivery company and a subsidiary of Lupin Limited since 2004. Nanomi develops and manufactures pharmaceutical products based on particles. The proprietary and versatile microfluidic Monosphere Technology enables the manufacturing complex injectable products in a robust, reproducible and cost effective way, from laboratory to commercial scale. The company was founded in 2004 and is located in Oldenzaal, in the East of the Netherlands. Nanomi was acquired by Lupin Limited in 2004 and has been since then a proud member of the Lupin family, focusing on the development of complex injectables. Nanomi's core technology is its proprietary Monosphere Technology based on microsieve emulsification. The technology enables the production of highly monodisperse droplets and particles for its use is pharmaceutical sustained release products in a robust, reproducible and cost effective way. Our sustained release injectables offer predictable size, superior injectability and taiRead more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nanomi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Nanomi, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Nanomi has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Nanomi
Click to see if Nanomi had a recent Job posting/layoffs
Earning: See what the market has to say on Nanomi recently announced quarterly report
Product Launch: Get notified when Nanomi launches new products
Funding: Get notified immidiatlly once Nanomi has new funding data
Check out if Nanomi is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Nanomi as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Nanomi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nanomi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nanomi.
Nanomi Tech Stack
A closer look at the technologies used by Nanomi
Most Recent Scoops
Open Position
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Open Position
Award
Award, Medical Research, Pharmaceuticals, Manufacturing Operations
Open Position
Nanomi News & Media
Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform
MUMBAI, India and NAPLES, Fla., Oct. 9, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of a strategic partnership program aimed at expanding the reach of PrecisionSphere™ – the...Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform
NAPLES, Fla., Sept. 10, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New...Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform
NAPLES, Fla., Sept. 10, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New...Nanomi erhält CMO-Auszeichnung für führende Rolle in der Medikamentenverabreichung
/PRNewswire/ -- Nanomi B.V., eine niederländische Tochtergesellschaft des globalen Pharmakonzerns Lupin Limited, gab heute bekannt, dass das Unternehmen...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nanomi
Sign Up For FreeTo access detailed company insights
Nanomi is a Dutch drug delivery company and a subsidiary of Lupin Limited since 2004. Nanomi develops and manufactures pharmaceutical products based on particles. The proprietary and versatile microfluidic Monosphere Technology enables the manufacturing complex injectable products in a robust, reproducible and cost effective way, from laboratory to... Read More
